Preventing adverse outcomes in ART-related twin pregnancies using aspirin

The effectiveness of low-dose aspirin (LDA) in reducing adverse pregnancy outcomes

Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries

April 11, 2024

Otsuka defies digital health downturn with new company

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Otsuka America, a subsidiary of the Japanese

May 29, 2024

Daré’s royalty deal; Qlaris Bio raises $24M

Plus, news about Newron and SynOx: Daré Bioscience inks royalty deal with XOMA: The company received $22 million, which is expected to help progress a

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.